Johnson & Johnsonwill need to pay more than $300m in penalties for deceptively marketing subsidiary Ethicon Inc.’s pelvic mesh products, a California appeals court ruled last week.
The ruling upholds $302m of a $344m verdict against the company handed down by a California trial court
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?